<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Aperio Secures $20 Million Series C Funding to Extend Leadership Position in Growing Digital Pathology Market	</title>
	<atom:link href="https://tissuepathology.com/2008/03/13/aperio-secures/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com/2008/03/13/aperio-secures/</link>
	<description>Educational and informative</description>
	<lastBuildDate>Sat, 08 Aug 2015 11:17:38 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>
		By: Christopher L. Hall		</title>
		<link>https://tissuepathology.com/2008/03/13/aperio-secures/#comment-395</link>

		<dc:creator><![CDATA[Christopher L. Hall]]></dc:creator>
		<pubDate>Thu, 13 Mar 2008 20:42:10 +0000</pubDate>
		<guid isPermaLink="false">http://tissuepathology.org/posts/pathology-news/aperio-secures/#comment-395</guid>

					<description><![CDATA[Dr. Kaplan:
Perhaps your masthead should read &quot;Digital Pathology Blog: A weblog for the digital pathology community, laboratory professionals, and certain generous vendors.&quot; Distributing press releases verbatim from one of your sponsors seems to jeopardize any claim at independence you may have, but perhaps that&#039;s not a concern for you.
]]></description>
			<content:encoded><![CDATA[<p>Dr. Kaplan:<br />
Perhaps your masthead should read &#8220;Digital Pathology Blog: A weblog for the digital pathology community, laboratory professionals, and certain generous vendors.&#8221; Distributing press releases verbatim from one of your sponsors seems to jeopardize any claim at independence you may have, but perhaps that&#8217;s not a concern for you.</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
